Treating venom allergy during COVID-19 pandemic
- PMID: 32677059
- PMCID: PMC7404889
- DOI: 10.1111/all.14473
Treating venom allergy during COVID-19 pandemic
Conflict of interest statement
The authors have nothing to disclose.
Figures
Comment in
-
Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic: Management of venom allergen immunotherapy during the COVID-19 outbreak in Spain.Allergy. 2021 Mar;76(3):951-952. doi: 10.1111/all.14567. Epub 2020 Oct 23. Allergy. 2021. PMID: 33095922 No abstract available.
References
-
- Bilò MB, Pravettoni V, Bignardi D, et al. Hymenoptera venom allergy: management of children and adults in clinical practice. J Investig Allergol Clin Immunol. 2019;29:180‐205. - PubMed
-
- Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73:744‐764. - PubMed
-
- Golden DB, Demain J, Freeman T, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118:28‐54. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical